Stay updated with breaking news from Robb Knie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to...
Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to implement a number of protocol amendments to its ongoing clinical trial for HT-001, which...
Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares are trading higher after the company announced the expansion of its FDA-cleared first-in-human clinical trial for cancer patients of
NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, announced today that it has received approval from the University of Miami to enroll...
NEW YORK, Dec. 5, 2023 /PRNewswire/ -- Hoth Therapeutics, Inc. , a patient-focused biopharmaceutical company, today announced it has completed the manufacturing of its drug substance HT-KIT using...